Novo Nordisk

Director, Medical Operations

Johnson & Johnson Innovative Medicine

Shaped and amplified patient-centric, data-driven innovation to deliver integrated solutions and differential value for the unmet needs of patients. 
•	Led enterprise-wide initiatives in oncology, immunology, and neuroscience leveraging novel data, advanced analytics and human-centred design capabilities to drive patient and business value.
•	Established strategic external partnerships with the healthcare eco-system, data aggregators and, patient organizations on unique patient-centric solutions.
•	Established an internal data and analytic technology environment to ingest data, accelerate insights, and scale assets and tools to drive efficiencies.

Director, Patient Value Innovation, Market Engagement Excellence

Established the Real World Evidence (RWE) strategy and strategic partnerships to support reimbursement efforts and advance RWE public policy 
•	Established four successful RWE partnerships with the governments of Alberta, Quebec, Newfoundland & Labrador, and Prince Edward Island to collaborate on mutually beneficial, high-value research initiatives.
•	Active in industry organizations on shaping RWE public policy to drive timely access to innovative treatments for patients. 
•	Built RWE capabilities to support evidence-generation needs by providing consultation on relevant data sources and analytical input and resources.

Director, Real World Evidence, Market Access and Government Affairs

Johnson & Johnson MedTech

Led a cross-functional Medical Affairs team supporting medical technology franchises in surgery, orthopedics, vision care, and interventional solutions.
•	Managed a diverse team that provided support in health economics, medical education, clinical affairs, and medical information across all MedTech teams.
•	Built strong external relationships with key opinion leaders, health technology assessment organizations, and the Canadian MedTech industry association (MEDEC) to advance MedTech public policy.

Director, Medical Affairs

Canadian Partnership Against Cancer

Executive responsibility to enable a pan-Canadian cancer control strategy with enhanced analytic and surveillance capabilities.
•	Managed technical teams to deliver initiatives with multi-disciplinary stakeholder advisory groups and strategic partnerships (health systems, government, and data organizations).
•	Successfully implemented: 1) infrastructure of cancer staging and synoptic pathology electronic systems in nine provinces; 2) a cancer control decision-making tool to project disease and economic impacts and 3) four pan-Canadian analytic networks to build data and analytic capacity.

Director, Analytics and Surveillance, Knowledge Management Division

Eli Lilly Canada

Managed a clinical operations team responsible for executing global trials in diabetes, osteoporosis, erectile dysfunction, sepsis, and human growth hormone. Responsible for ensuring resources were optimized to meet all key milestones and business planning targets for clinical trials.

Sr. Manager, Clinical Research Operations

Led cross-functional teams on high-priority Sales and Marketing projects focused on improving critical business processes to better meet customer needs, drive efficiency and increase profitability. Worked closely with the regional president and senior leadership team to prioritize issues, implement solutions and manage ongoing performance.

Six Sigma Black Belt

Responsible for directing one of three Lilly Global Centers of Excellence in Statistics. Managed a team of statisticians, analysts, medical writers, and vendors that supported global R&D product teams in designing clinical trials, developing statistical analysis plans, performing data locks, and contributing to scientific publications.

Manager, Statistics and Information Sciences

Innovative, agile, and results-oriented life sciences executive with over twenty years of experience in healthcare leadership roles in the public and private sectors. Passionate in mentoring and developing teams.  A collaborative leader with the ability to identify opportunities from complex problems. Strong strategic, analytical, and operational experience across multiple therapeutic areas including oncology, immunology, neuroscience, and rare diseases. Broad-based leadership in R&D, Medical Affairs, Market Access & Government Affairs, MedTech, and Data & Analytics.

Taplio

Janey Shin, MSc, MBA's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Janey Shin, MSc, MBA's Linkedin Analytics

Want to drive more opportunities from LinkedIn?

Janey Shin, MSc, MBA's Linkedin Analytics